Description
ARA-290 10mg Core Specifications
Deep technical specification parameters optimized for integrating 10mg ARA-290 into focused, multi-well laboratory screening protocols.
| Research Parameter | Assay Benchmark Profile | Internal Catalog Link |
|---|---|---|
| Sequence Blueprint | Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (11-AA Helix B Derived Peptide) | High-Purity Series → |
| Molecular Weight | 1257.4 Da (Stabilized, short linear peptide architecture) | |
| Purity Baseline | ≤ 98.0% via High-Performance SEC-HPLC | Anti-Aging Compounds → |
| Assay Target | Selective Innate Repair Receptor (IRR) Heterodimer Activation |
What is ARA-290 Peptide & How Does it Work?
What is ARA-290 Peptide & How Does it Work?
ARA-290 (also documented as Cibinetide) is a premier synthetic 11-amino-acid peptide derived from the detailed 3D structure of erythropoietin (EPO), specifically copying its non-hematopoietic Helix B loop section. While it retains the core tissue protective and anti-inflammatory properties of the parent molecule, ARA-290 possesses a distinct structural layout that prevents it from binding to classic homodimeric EPO receptors responsible for red blood cell production. Because of this specialized design, it avoids altering hematocrit layers or blood viscosity indicators during testing. In modern biology research, this 10mg format serves as an ideal reference standard for exploring peripheral nerve repair, cellular survival, and localized boundary defense trends over extended testing phases without facing background blood-proliferation noise.
ARA-290 10mg Quick Specifications
| Technical Property | Laboratory Standard Specifications |
|---|---|
| Chemical Structure | Linear 11 Amino Acid Peptide Sequence (Erythropoietin Helix B Fragment) |
| Active Core Payload | 10mg Purified Crystalline Powder / Vial (Focused Titration Setup) |
| Purity Baseline | ≥ 98.0% Pure Certified via HPLC Testing Rows |
| Primary Research Focus | Selective Innate Repair Receptor heterodimer binding, nerve survival, and cytokine suppression |
How Does ARA-290 Work in Laboratory Assays?
ARA-290 operates primarily by binding selectively into the Innate Repair Receptor (IRR), which is a unique heterodimeric structure made of erythropoietin receptors and beta-common receptor subunits that cells display during periods of tissue stress or physical trauma. This specific binding activation shuts down the intracellular pathways driving cellular inflammatory responses, blocking downstream pro-inflammatory cytokines like TNF-alpha and IL-6. Concurrently, it prompts protective signaling paths that secure peripheral small nerve fiber survival and maintain endothelial tight junctions natively.
ARA-290 Research Applications & Action Mechanisms
ARA-290 Research Applications & Action Mechanisms
In analytical neurology, immunology, and tissue survival publications, ARA-290 is heavily tracked for its capability to stimulate peripheral nerve fiber repair and reverse small fiber neuropathy indications. Investigators utilize this stable 10mg presentation format to build exact concentration parameters and observe cell survival rates across stressed or low-oxygen tissue culture matrices. This focused configuration is highly favored for multi-well plate setups, letting researchers set up comprehensive response graphs entirely from a single production batch to avoid lot variance issues.
ARA-290 Core Pathways & Action Matrix
| Target Pathway | Observed Cellular Action | Primary Research Goal |
|---|---|---|
| IRR Heterodimer Agonism | Binds exclusively to active tissue protective receptor sites to prompt immediate repair cascades. | Quantifying localized nerve fiber recovery speeds. |
| Neuropathic Defense | Protects peripheral axon boundaries, decreasing cell death rates in damaged nerve rows. | Measuring the survival of small diameter unmyelinated fibers. |
| Non-Erythropoietic loop | Bypasses classic red blood cell production channels completely, avoiding hematocrit changes. | Isolating tissue protection from cardiovascular parameter changes. |
Step-by-Step Mechanism of Action
When ARA-290 is introduced into targeted neural research media, it coordinates deep tissue adaptations through a highly standardized sequence path:
- IRR Selective Alignment: The 11 amino acid linear chain links cleanly with the heterodimeric tissue protective receptor complex.
- Anti-Apoptotic Driving: Blocks the internal pathways responsible for programming cell death in threatened tissue arrays.
- Cytokine Suppression: Shuts down the output of destructive tissue-destroying signaling elements near cell boundaries.
- Axonal Stabilization: Prompts small nerve fiber axons to regrow and stabilize their outer shield layouts, recovering structural cellular baseline values.
How Does ARA-290 Compare to Other Peptides?
How Does ARA-290 Compare to Other Peptides?
To assist in protocol coordination, it is essential to differentiate the IRR selective tissue-protective focus of ARA-290 10mg from alternative short anti-inflammatory fragments, selective secretagogues, or global cellular coenzymes available in our collection. While alternative options investigate localized boundary restoration, isolated somatotroph pulses, or global mitochondrial respiratory loops, ARA-290 focuses on peripheral neuropathic protection. Understanding these baseline differences allows for more precise laboratory assay designs.
Peptide Quick Comparison Matrix
The comparative table below outlines the core differences in research focus, mechanism of action, and primary target nodes across our high-purity laboratory catalog:
| Research Peptide | Mechanism of Action | Primary Laboratory Focus | Target Nodes | Peptide Structure |
|---|---|---|---|---|
| ARA-290 10mg(This Product) | Selective IRR Heterodimer Agonism | Peripheral small nerve protective mapping, localized tissue repair, and erythropoiesis-free lines. | IRR Complex (Helix B) | Linear Core (11-AA) |
| KPV 10mg | Intracellular NF-kB Inhibition | Epithelial barrier repair mapping, non-hormonal anti-inflammatory cell loops, and tight junction preservation. | Intracellular Cytoplasm | Tripeptide (3-AA) |
| Ipamorelin 5mg | Selective GHSR Agonism | Isolated growth hormone pulse tracking, lipolytic speed mapping, and cellular mass accumulation tracking. | Ghrelin Receptor | Pentapeptide (5-AA) |
| NAD+ 1000mg | Sirtuin Enzyme Substrate | Mitochondrial respiration mapping, sirtuin deacetylation, and global cellular energy restoration. | SIRT1-7 / Mitochondria | Purified Coenzyme |
Synergistic Research Application Notice
In analytical tissue biology lines, investigators frequently study Helix B-derived sequences alongside short-chain immunomodulators like KPV to map comparative cellular rescue thresholds across inflamed nerve cultures. The stable 10mg format provides excellent concentration accuracy, allowing researchers to run exact pilot trials without lot variance disruptions. While alternative catalog rows explore broad energy kinetics or secretagogue loops, standalone ARA-290 remains the absolute standard for non-hematopoietic neural repair analysis.
How to Store ARA-290 Lyophilized Powder & Liquid Solutions
How to Store ARA-290 Lyophilized Powder & Liquid Solutions
To keep your high-purity ARA-290 peptide stable and prevent its specific 11 amino acid chain sequence from breaking down early, you must follow strict temperature parameters. Proper handling ensures that your laboratory assay baselines remain fully consistent and free from structural degradation artifacts over time.
- FREEZER (-20°C) Lyophilized Peptide Powder: Store the dry crystalline powder vial inside a laboratory freezer at -20°C to -80°C for long-term storage. This fully seals the peptide configuration against sequence decay for up to 24 months.
- ROOM TEMP (25°C) Shipping & Transit Window: In its dry, vacuum-desiccated solid state, ARA-290 is highly resilient. It can easily endure ambient transport fluctuations up to 25°C for a maximum of 3 weeks. Always return the vials to deep-freeze storage upon delivery.
- REFRIGERATOR (2°C – 8°C) Reconstituted Liquid Phase: Once mixed into a liquid form, the solution must be stored strictly under refrigeration between 2°C and 8°C. Reconstituted fluid phases face natural structural decay; completely exhaust the active liquid within 10 to 14 days maximum. Never freeze a peptide after it has been liquified.
Step-by-Step ARA-290 Reconstitution Guide
Because short-chain peptide matrices are sensitive to sudden physical pressure shifts, follow this precise protocol to dissolve your 10mg ARA-290 powder cake into a stable fluid layer:
- Temperature Adjusting: Allow the 10mg ARA-290 vial to naturally reach ambient room temperature equilibrium before removing the plastic security cap. This step blocks condensation moisture from contaminating the dry cake.
- Sanitizing the Septum: Thoroughly clean the upper rubber entry core septum using a fresh, high-grade isopropyl alcohol sterile wipe.
- Gentle Liquid Cascade: Draw your laboratory diluent (such as sterile bacteriostatic water) and slowly inject 1ml down the internal glass envelope wall. Let the fluid cascade gently down the glass rather than spraying it directly at the powder to avoid structural kinetic shock paths.
- Zero Aggressive Agitation: Do not shake, vibrate, or vortex the vial. Mechanical friction shears peptide structures easily. Instead, gently roll and rotate the vial horizontally in circular, concentric movements until the white solid cake fully transitions into a pristine, crystal-clear transparent liquid layer.
There are no reviews yet.